Effect of Interleukin-2 on HIV Treatment Interruption

NCT00015704 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Aldesleukin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)